![Matthew Batters](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Batters
General Counsel at
APOGEE THERAPEUTICS, INC.
Profile
Matthew Batters is currently Secretary & Chief Legal Officer at Apogee Therapeutics, Inc. since 2024.
Formerly, Mr. Batters was Vice President-Business Development & Counsel at Arvinas, Inc. from 2018 to 2023, Senior Director-Transactions at Alexion Pharmaceuticals, Inc. from 2014 to 2018, Corporate Associate at DLA Piper LLP (United States) from 2006 to 2014, and Associate at Skadden, Arps, Slate, Meagher & Flom LLP from 2006 to 2010.
Education includes graduate degrees from the University of London and Columbia Law School, and an undergraduate degree from the University of Bristol.
Matthew Batters active positions
| Companies | Position | Start |
|---|---|---|
| APOGEE THERAPEUTICS, INC. | General Counsel | 2023-07-31 |
Former positions of Matthew Batters
| Companies | Position | End |
|---|---|---|
| ARVINAS, INC. | General Counsel | 2023-07-31 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2018-01-31 |
DLA Piper LLP (United States)
 DLA Piper LLP (United States) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 2014-06-30 |
Skadden, Arps, Slate, Meagher & Flom LLP
 Skadden, Arps, Slate, Meagher & Flom LLP Miscellaneous Commercial ServicesCommercial Services Operates as a legal firm | Corporate Officer/Principal | 2010-08-31 |
Training of Matthew Batters
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
71
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Skadden, Arps, Slate, Meagher & Flom LLP
Skadden, Arps, Slate, Meagher & Flom LLP Miscellaneous Commercial ServicesCommercial Services Operates as a legal firm | Commercial Services |
DLA Piper LLP (United States)
DLA Piper LLP (United States) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia Law School
 Columbia Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Apogee Therapeutics, Inc.
 Apogee Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops therapies for immunological and inflammatory disorders | Health Technology |
- Stock Market
- Insiders
- Matthew Batters
